Absci to Participate in the 26th Annual Needham Growth Conference
VANCOUVER, Wash. and NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq:ABSI), a generative AI drug creation company, today announced the company will be participating virtually in the upcoming 26th Annual Needham Growth Conference.
Related news for (ABSI)
- Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial
- 24/7 Market News Snapshot 15 October, 2025 – Absci Corporation Common Stock (NASDAQ:ABSI)
- MoBot’s Stock Market Highlights – 05/14/25 09:00 AM
- Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
- 24/7 Market News Snapshot 13 May, 2025 – Absci Corporation Common Stock (NASDAQ:ABSI)